SAFC, the custom manufacturing and business services wing of Sigma Aldritch, has announced a licensing agreement with biotech company, Agilent Technologies, for the sale of its nucleic acids synthesis products and technologies.
Agilent Technologies is expanding its nucleic acid active
pharmaceutical ingredient (API) manufacturing facility in Boulder,
Colorado, US, as the industry gravitates towards the
development of oligonucleotide-based drugs.
Agilent's purchase of DowPharma's Nucleic Acid Medicines business
is the second time in recent years that the US scientific
measurements specialist has ramped-up its nucleic acid
The expiration of the Polymerase Chain Reaction (PCR) patent is set
to offer growth opportunities for nucleic acid purification and
amplification technologies, particularly for small companies, who
can offer tests without developing...
Kreatech Biotechnology launches a series of nucleic acid labelling
kits for in situ hybridisation and filter hybridisation
applications. These kits offer the researcher the possibility to
non enzymatically label their target nucleic...
Degussa has agreed to sell its nucleic acid unit Proligo to
Sigma-Aldrich for an undisclosed purchase price, on the grounds
that it does not have the resources in-house to grow Proligo from
its current sixth place ranking in the sector.
Qiagen has launched the world's first automated sample preparation
system for viral nucleic acids to aid molecular diagnostics that
conforms to a European Union Directive on in vitro diagnostic
Invitrogen, which supplies reagents, services and software for the
life science market, has continued its acquisitive streak with the
announcement that it is paying $35 million (€27.5m) for a UK firm -
DNA Research Innovations - specialising...
Germany's MWG Biotech has said it will slash nearly two thirds of
its workforce in a further effort to reduce costs, prompting
speculation about the long-term future of the company in its
Qiagen has sold off its embattled nucleic acid synthesis business
in a management buyout, but has retained a minority stake and all
activities relating to RNA interference (RNAi), a potent new drug
Scientists at the California Institute of Technology in the US have
developed a postage stamp-sized chip that can be used to carry out
many of the routine steps involved in isolating and purifying
nucleic acids from cells.